DMBA invariably induces HRas activating mutations, while TPA promotes tumor growth by deregulating several signaling networks, including the PKC-Ras/MAPK cascade that mediates proliferation, differentiation and inflammation [42–44]. The gene discussed is PRRT2; the disease is neoplasm.